Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Enoxaparin 40 mg
DRUG
2 trials
Sponsors
Janssen Research & Development, LLC
, Peking University People's Hospital
Conditions
Arthroplasty, Replacement, Knee
Hypoalbuminemia
Nephrotic Syndrome
Phase 2
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
Completed
NCT03891524
Janssen Research & Development, LLC
Arthroplasty, Replacement, Knee
Start: 2019-06-17
End: 2021-04-06
Updated: 2025-03-30
Unknown Phase
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
Not yet recruiting
NCT07116239
Peking University People's Hospital
Hypoalbuminemia, Nephrotic Syndrome
Start: 2025-09-30
End: 2026-02-28
Target: 60
Updated: 2025-08-11
Related Papers
Milvexian for the Prevention of Venous Thromboembolism
New England Journal of Medicine
2021-11-15
234 citations